Clinical trial Recruiting at 1 site Observational Ages 18 and up

Managing antithrombotic use during colonoscopy

Official title: Prospective Collection of Clinical and Laboratory Variables of Patients Receiving Antithrombotics and Requiring Colonoscopy

Run by Chinese University of Hong Kong · NCT03363061 · Data updated 2026-11-12

This study looks at how to safely manage blood-thinning medications for patients having a colonoscopy to see how it affects their risk of bleeding and blood clots.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment6000 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedDecember 8, 2017
Main results expectedNovember 30, 2027
Study endsNovember 30, 2028
Registry record updatedJanuary 18, 2022
Trial IDNCT03363061 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old who are scheduled for elective colonoscopy and are currently receiving antithrombotic therapy.

Probably not a fit

Patients under 18 years of age or those unable to provide informed consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients who are on antithrombotics and are scheduled for elective colonoscopy. It aims to evaluate the management strategies for antithrombotic therapy in the context of invasive procedures, particularly the balance between the risks of thromboembolism and bleeding. The study will analyze the current practices and outcomes associated with antithrombotic use during colonoscopy, addressing the gaps in knowledge regarding bleeding risks. By utilizing data from patients undergoing this common procedure, the study seeks to provide insights into optimal management strategies.

Why it matters

Potential benefit: If successful, this study could lead to improved guidelines for managing antithrombotic therapy in patients undergoing colonoscopy, enhancing patient safety.

How similar studies have gone: While there is ongoing research in this area, the specific management of antithrombotics during colonoscopy remains underexplored, making this study a novel contribution.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients must be over 18 years of age
* Patients undergoing elective colonoscopy for any indication, who are receiving antithrombotics
* Informed consent is obtained

Exclusion Criteria:

* Patients under 18 years of age
* Inability to give informed consent

Where it's running

  • Prince of Wales Hospital
    Hong Kong, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: Moe Htet Kyaw, MBBS — Chinese University of Hong Kong
  • Study coordinator: Moe Htet Kyaw, MBBS
  • Email: moehkyaw@cuhk.edu.hk
  • Phone: 35053476

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.